Mitral valve-in-valve and valve-in-ring for failing surgical bioprosthetic valves and rings.

The transcatheter valve-in-valve (VIV) procedure for failed aortic bioprostheses is recognized as an alternative treatment to conventional surgery in high-risk patients. This less invasive option has now been applied to failed mitral bioprostheses (VIV) or failed repairs i.e.

Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach.

Objectives: To evaluate feasibility and outcome of Transoartic Transcatheter Sapien valve implantation.

Background: Transcatheter Aortic valve implantation (TAVI) using the Edwards SAPIEN device (Edwards LifeScience, Irvine, CA) is usually performed via the transfemoral (TF) or transapical (TA) routes. Some patients are not suitable for these approaches.